RTHawk

by HeartVista Cardiac Package  · Based in United States → — AI-Powered One-Click Cardiac MRI for Enhanced Diagnostics
Cardiology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

The HeartVista Cardiac Package, featuring RTHawk, is an advanced AI-driven software platform designed to revolutionize cardiac Magnetic Resonance Imaging (MRI) by simplifying and accelerating the acquisition process. It integrates with existing MRI scanners, notably from GE and Siemens Healthineers, to provide a comprehensive suite of tools for cardiac exams. The software leverages artificial intelligence to automate the prescription of standard cardiac views with a single click, significantly reducing scan times and the need for extensive breath-holds. This automation makes cardiac MRI more accessible to a broader patient population, including those with arrhythmias or difficulties holding their breath. The package incorporates a unique artifact detection neural network to ensure optimal image quality and offers preliminary measurements of left ventricular function, such as ejection fraction, volumes, and mass. Beyond clinical applications, RTHawk also serves as a research platform, providing GUI-based design tools for developing new MRI applications. The company, originally HeartVista, rebranded to Vista.ai to reflect its expansion beyond cardiac-specific MRI solutions to other anatomies like prostate and musculoskeletal imaging.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-assisted MRI acquisition software
  • One-Click Cardiac Package MRI software
  • Real-time, free-breathing, and breath-hold sequences for cardiac exams
  • Automates standard cardiac views
  • Artifact detection neural network
  • Optimizes inversion time with AI assistance
  • 4D flow measurement application
  • Provides preliminary measures of left ventricular function (ejection fraction, volumes, mass)
  • Compatible with GE and Siemens Healthineers MRI scanners
  • GUI-based design tools for MRI research (RTHawk Research)

Use Cases

  • Diagnosing heart disease via cardiac MRI
  • Improving efficiency and accuracy of cardiac MRI scans
  • Making cardiac MRIs more accessible to patients (e.g., those with arrhythmia, unable to hold breath)
  • Reducing scan time and complexity for MRI technologists
  • Research and development of new MRI applications
  • Expanding MRI capabilities beyond cardiac to other anatomies (e.g., prostate, musculoskeletal)

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentOn-premise (integrated with existing MRI scanners)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

HeartVista's AI-assisted One Click Cardiac MRI Package received 510(k) clearance from the U.S. Food and Drug Administration (K183274) on October 18, 2019, for its AI-assisted acquisition software for cardiac exams.
Integrations
EHR Not specified
Specialties Cardiology, Radiology

What the Web Says

RTHawk, developed by Vista AI, is an AI-driven MRI software platform designed to streamline MRI exams and facilitate the rapid development of custom imaging applications. It integrates with clinical workflows and is used by leading institutions for research. The software aims to enhance consistency and productivity in MRI studies, particularly in cardiac MRI, and is expanding to other anatomical areas.

Overall: Positive

Strengths

  • Enhances consistency and productivity in MRI studies.
  • Automates MRI scanning, enabling accurate, high-quality scans.
  • Reduces scan time significantly (e.g., from 25-30 minutes to 5-10 seconds for certain views).
  • Streamlines workflows and helps reduce backlogs.
  • User-friendly interface for designing pulse sequences (SpinBenchu2122).
  • Supports advanced reconstruction techniques and real-time data processing.

Limitations

  • Some advanced features and customization options may take time to learn for new administrators.
  • Limited reviews available on platforms like G2 and Capterra specifically for RTHawk, making comprehensive sentiment analysis challenging.
  • Potential initial concerns from technologists regarding AI integration into their jobs.

Based on reviews from: Vista AI, Aletia Index, HealthAidb, FeaturedCustomers, YouTube (The Cardiac Wire Show)

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate RTHawk

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Vista AI (Press Release)
Vista AI Secures $29.5M in Series B Funding as Health Systems Back Automated MRI Scanning
Vista AI, Inc. announced the closing of $29.5 million in Series B financing, with new investors including several health systems, to expand its FDA-cleared cardiac MRI platform into additional anatomies like brain, prostate, and spine.
2026-01
HLTH
Vista AI Raises $29.5M Series B with Strategic Backing from Health Systems
Vista AI secured $29.5 million in Series B funding from health systems and venture investors to scale its FDA-cleared cardiac MRI platform and expand into other anatomical areas, addressing the shortage of trained MRI technologists.
2026-01
Vista AI (Press Release)
Two-Year Data Proves Vista AI Scan Delivers Faster, More Reliable MRI Scans
Vista AI announced two-year clinical results from Brigham and Women's Hospital demonstrating that Vista AI Scan, its automated image acquisition software, improves workflow efficiency, image quality, and consistency in cardiac MRI studies.
2024-12
Vista AI (Press Release/Video)
How Vista AI Increases Cardiac MRI Access: RSNA Presentation
A presentation from RSNA 2024 by Dr. Sean Hughes of Vanderbilt University Medical Center discusses how Vista AI's automation solutions can address challenges in cardiac MRI programs, streamline workflows, and expand access to high-quality CMR.
2024-12
Business Wire
Vista.ai Appoints MedTech Veteran Daniel Hawkins as Chief Executive Officer
Vista.ai announced the appointment of Daniel Hawkins as President and CEO, who joins the company after its initial FDA clearance and early commercialization of its cardiac MRI product, with plans to expand to brain, spine, and other indications.
2024-03
Vista AI (Press Release)
Clinical Study Shows Vista AI Significantly Reduces Cardiac MRI Scan Time
A clinical adaptation study led by Dr. Raymond Kwong at Brigham and Women's Hospital showed that Vista AI Scan software improved cardiac MRI scan times and achieved high adoption rates among hospital imaging staff.
2023-01
PR Newswire
HeartVista to Expand Beyond Heart MRIs, Changes Name to Vista.ai to Reflect Wider Focus
HeartVista announced its rebranding to Vista.ai, signaling an expansion beyond cardiac MRI to simplify and enhance MRI exams for other anatomies, with clinical studies already underway for prostate and musculoskeletal scans.
2022-11
FDA
510(k) Summary RTHawvk 510(k) Number: K133848
This FDA 510(k) summary details the clearance of RTHawk, or HeartVista Workstation with RTHawk, as an accessory to 1.5 and 3.0T whole-body magnetic resonance systems, optimized for cardiovascular MR imaging.
2014-06

Videos

Product demos, reviews, and walkthroughs for RTHawk.

View all on YouTube

Frequently Asked Questions

The accuracy of AI tools like RTHawk in clinical decision-making can be comparable to human experts in specific, well-defined tasks, but performance is highly dependent on the quality and representativeness of its training data. Physicians should exercise caution and not over-rely on AI, as it may struggle with incomplete or inconsistent real-world data and lacks human contextual understanding.
RTHawk must adhere to rigorous data governance and security controls to ensure HIPAA compliance, particularly concerning the processing of Protected Health Information (PHI). It is crucial that the vendor prohibits the use of patient data for training or retraining models without explicit patient authorization. Regulatory oversight for medical AI is evolving, with varying levels of FDA scrutiny depending on the tool's risk classification and function.
AI systems like RTHawk can exhibit biases if trained on incomplete or skewed datasets, potentially leading to inequitable outcomes or discrimination in patient care. Furthermore, AI lacks the human capacity for empathy, intuition, and holistic reasoning, meaning physicians remain essential for sensitive patient communication and comprehensive care.
Alternatives to RTHawk include other proprietary AI diagnostic tools, open-source AI models, and traditional clinical methods without AI augmentation. RTHawk would differentiate itself through its specific clinical use cases (e.g., imaging, documentation, decision support), its integration capabilities with existing systems, and validated clinical outcomes.
Pricing models for healthcare AI solutions like RTHawk can vary, including subscription-based fees, consumption-based (pay-per-use) models, fixed costs for specific projects, or customized enterprise solutions. Beyond the licensing or subscription, associated costs typically include development, data management, infrastructure, integration with Electronic Health Records (EHR), and ongoing maintenance and support.
Seamless integration with existing EHR/EMR systems is a critical factor for the effective adoption of AI tools like RTHawk within clinical workflows. Comprehensive training for physicians and staff is essential, covering not only the technical usage of the tool but also when to appropriately rely on its recommendations and how to accurately document its use.
The question of liability for AI errors in healthcare is still evolving, but existing legal frameworks are expected to adapt to address these unique challenges. Ultimately, healthcare practices remain responsible for ensuring compliance and managing risks, even when utilizing third-party AI vendors.

Compare RTHawk

VS
RTHawk vs EchoNext
Cardiology AI Adjacent · 65/100
RTHawk and EchoNext are adjacent competitors in cardiology AI, both FDA-cleared, but focus on different diagnostic modalities. RTHawk enhances cardiac MRI acquisition and analysis, providing real-time imaging and…
VS
V7 Diagnostic Ultrasound System vs RTHawk
Cardiology AI Adjacent · 65/100
These tools are adjacent competitors, both leveraging AI for cardiovascular and radiology applications. Tool A, the Samsung V7, is a complete ultrasound system with AI features for various…
VS
CardIQ Suite vs RTHawk
Cardiology AI Adjacent · 65/100
These tools are adjacent rather than direct competitors, as CardIQ Suite specializes in AI-powered post-processing and analysis of cardiac CT scans for diagnosis and treatment planning. In contrast,…
VS
Lung AI vs RTHawk
Cardiology AI Adjacent · 60/100
These tools offer adjacent but not directly comparable solutions for cardiac imaging. Lung AI provides AI-powered analysis for handheld ultrasound devices, focusing on real-time, accessible diagnostics for cardiac…

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
Paid, credit-based or subscription
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Contact for pricing
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.